⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Pomerantz LLP Issues Important Reminder to Investors in ARS Pharmaceuticals, Inc. of Class Action – SPRY
accessnewswire.com
SPRY
Securities Class Action Lawsuit Filed Against ARS Pharmaceuticals, Inc. (SPRY) - Levi & Korsinsky Represents Shareholders
accessnewswire.com
SPRY
SPRY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
SPRY
Kaplan Fox Urges ARS Pharmaceuticals Inc. (SPRY) Investors Seeking Recovery to Contact the Firm Before October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
SPRY DEADLINE: Levi & Korsinsky Reminds ARS Pharmaceuticals Inc. Investors of Upcoming Securities Class Action Deadline
prnewswire.com
SPRY
SPRY SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
Securities Fraud Class Action Filed Against ARS Pharmaceuticals, Inc. (SPRY) - Levi & Korsinsky Reminds Investors of October 5, 2026
accessnewswire.com
SPRY
Pomerantz LLP Issues Important Reminder to Investors in ARS Pharmaceuticals, Inc. of Class Action – SPRY
accessnewswire.com
SPRY
Class Action Lawsuit Filed Against ARS Pharmaceuticals, Inc. (SPRY) - Recover Losses - Contact Levi & Korsinsky Before October 5, 2026
accessnewswire.com
SPRY
Investor Alert: Deadline Approaching to Join ARS Pharmaceuticals, Inc. (SPRY) Class Action - Contact Levi & Korsinsky
accessnewswire.com
SPRY